AstraZeneca (AZN) Gains on Liberum Upgrade

November 25, 2016 8:57 AM EST
Get Alerts AZN Hot Sheet
Price: $27.10 +0.11%

Rating Summary:
    13 Buy, 7 Hold, 4 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 24 | Down: 17 | New: 14
Trade AZN Now!
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

AstraZeneca (NYSE: AZN) is higher in early trade after Liberum upgraded the stock from Hold to Buy and set a £52.00 price target.

The analyst noted with shares at 2013 lows, the market is placing zero value on the company's high risk but high-reward immuno-oncology franchise.

Shares of AstraZeneca last traded up 2.8% to $27.11 in the U.S.

For an analyst ratings summary and ratings history on AstraZeneca click here. For more ratings news on AstraZeneca click here.

Shares of AstraZeneca closed at $26.37 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, Hot Upgrades, Upgrades

Add Your Comment